[HTML][HTML] Donepezil: A review of the recent structural modifications and their impact on anti-Alzheimer activity

M Ahmad - Brazilian Journal of Pharmaceutical Sciences, 2020 - SciELO Brasil
Alzheimer disease (AD) is characterized by a low level of acetylcholine, beta-amyloid (Aβ)
aggregation and oxidative stress. Donepezil is the core medicine used for the treatment of …

UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes

M Novak, B Svobodova, J Konecny, A Kuratkova… - … of Pharmaceutical and …, 2023 - Elsevier
Tacrine was the first drug used in the therapy of Alzheimer's disease (AD) and is one of the
leading structures frequently pursued in the drug discovery of novel candidates for tackling …

Social and family load of Alzheimer's disease

P Maresova, H Mohelska, K Kuca - Applied Economics, 2016 - Taylor & Francis
ABSTRACT As the World Health Organization reports, mental illnesses have a serious
impact on more than 25% of all population people worldwide at some time during their lives …

[HTML][HTML] Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists

M Chvojkova, D Kolar, K Kovacova, L Cejkova… - Biomedicine & …, 2024 - Elsevier
Therapeutic options for Alzheimer's disease are limited. Dual compounds targeting two
pathways concurrently may enable enhanced effect. The study focuses on tacrine …

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy

H Boulebd, L Ismaili, M Bartolini, A Bouraiou… - Molecules, 2016 - mdpi.com
Herein we describe the synthesis and in vitro biological evaluation of thirteen new, racemic,
diversely functionalized imidazo pyranotacrines as non-hepatotoxic, multipotent tacrine …

Chiral bistacrine analogues: synthesis, cholinesterase inhibitory activity and a molecular modeling approach

JPB Lopes, JS Costa, MA Ceschi… - Journal of the Brazilian …, 2017 - SciELO Brasil
Cholinesterase enzymes are important targets for the therapy of Alzheimer's disease.
Tacrine-based dual binding site cholinesterases inhibitors are potential disease-modifying …

Recent modifications of anti-dementia agents focusing on tacrine and/or donepezil analogs

LW Mohamed, KO Mohamed, HS Sayed… - Medicinal …, 2023 - ingentaconnect.com
Alzheimer's Disease (AD) is a multifactorial incurable neurodegenerative disorder. It is
characterized by a decline of cholinergic function in parallel with β-amyloid fibril deposition …

In vitro effects of cognitives and nootropics on mitochondrial respiration and monoamine oxidase activity

N Singh, J Hroudová, Z Fišar - Molecular Neurobiology, 2017 - Springer
Impairment of mitochondrial metabolism, particularly the electron transport chain (ETC), as
well as increased oxidative stress might play a significant role in pathogenesis of …

Synthesis, Pharmacological Study and Docking Calculations of New Benzo[f]coumarin Derivatives as Dual Inhibitors of Enzymatic Systems Involved in …

MJ Matos, P Janeiro, RM Gonzalez Franco… - Future Medicinal …, 2014 - Taylor & Francis
Background: Due to the complex etiology of neurodegenerative diseases, there is growing
interest in multitarget drugs. In this study we synthesized and evaluated a new series of …

A 7-methoxytacrine–4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication

E Nepovimova, J Korabecny, R Dolezal… - Toxicology …, 2016 - academic.oup.com
Chemical warfare agents constitute an increasing threat to both military and civilian
populations. Therefore, effective prophylactic approaches are urgently needed. Herein, we …